Oppenheimer Cuts Æterna Zentaris (AEZS) to Perform
Tweet
Share
E-mailGet Alerts AEZS Hot Sheet
Price: $1.96 -0.51%
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Oppenheimer's Boris Peaker downgraded his investment rating on shares of Æterna Zentaris (NASDAQ: AEZS) from Outperform to Perform Monday afternoon amid news trials of Keryx's KRX-0401 with Xeloda did not meet Phase 3 endpoints.
For an analyst ratings summary and ratings history on Æterna Zentaris click here. For more ratings news on Æterna Zentaris click here.
For an analyst ratings summary and ratings history on Æterna Zentaris click here. For more ratings news on Æterna Zentaris click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Monster Beverage (MNST) to Neutral, 'Cost Pressures and Weaker Low-end Consumer'
- Truist Securities Downgrades HashiCorp Inc (HCP) to Hold
- Monster Beverage (MNST) cut to sell at Truist as its 'no longer see it as a high growth story'
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
